Sectoral Asset Management’s Structure Therapeutics GPCR Stock Holding History

Sectoral Asset Management’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Sell	4,325 -9,777	-69%	-$433K	0.16%	77
2026 Q1	$711K	Sell	14,102 -9,770	-41%	-$669K	0.59%	45
2025 Q4	$1.66M	Sell	23,872 -198,000	-89%	-$8.08M	1.33%	23
2025 Q3	$6.21M	Buy	221,872 +170,503	+332%	+$3.4M	3.83%	3
2025 Q2	$1.07M	Buy	51,369 +17,674	+52%	+$389K	0.7%	47
2025 Q1	$583K	Sell	33,695 -15,555	-32%	-$381K	0.45%	51
2024 Q4	$1.34M	Buy	49,250 +24,855	+102%	+$882K	0.89%	30
2024 Q3	$1.07M	Buy	24,395 +11,030	+83%	+$427K	0.63%	49
2024 Q2	$525K	Buy	13,365 +7,401	+124%	+$304K	0.21%	65
2024 Q1	$256K	Buy	5,964 +2,564	+75%	+$108K	0.1%	85
2023 Q4	$139K	Buy	+3,400	New	+$195K	0.06%	101

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Sectoral Asset Management's GPCR Position: Q2 2026 in Review

Sectoral Asset Management reduced its Structure Therapeutics (GPCR) stake by 69% in Q2 2026, selling an estimated $433K and leaving 4,325 shares worth $232K. The position accounts for 0.16% of the portfolio, ranked #77.

Sectoral Asset Management first reported a position in GPCR in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.21M in Q3 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Sectoral Asset Management held 4,325 shares of Structure Therapeutics worth $232K as of Q2 2026.
Sectoral Asset Management sold 9,777 Structure Therapeutics shares in Q2 2026, an estimated $433K.
Structure Therapeutics made up 0.16% of Sectoral Asset Management's portfolio in Q2 2026, its #77 holding.
Sectoral Asset Management first reported a position in Structure Therapeutics in Q4 2023 and has held it in 11 quarters since.
Sectoral Asset Management's Structure Therapeutics position peaked at $6.21M in Q3 2025.
192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.